16 May
For the first time in Israel, Hadassah Medical Organization (HMO) working in collaboration with Israeli company P-Cure, is now able to provide ground-breaking experimental proton radiation treatment to cancer patients. This treatment is more precise and efficient, safer, with fewer side effects than any other treatment available. In the past, Israeli patients who wanted […]
READ MORE17 Dec
A Phase 2 study at Hadassah Hospital Ein Kerem has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat neurodegenerative diseases. The 14-month randomized, double blind, placebo-controlled study, comprised of 48 patients, was led by Prof. […]
READ MORE25 Sep
Hadassah is set to begin a clinical trial with an Israeli-made COVID-19 vaccine in October. One hundred volunteers are being recruited to participate at Hadassah and Tel Aviv’s Sheba Medical Centre. The vaccine, developed by the Israel Institute for Biological Research (IIBR), was tested successfully on hamsters. IIBR announced in June that hamsters who were given its vaccine and […]
READ MOREHadassah UK © 2022 | w/creators with Web Studio Lab
Join our digital newsletter to stay in touch with the latest news from Hadassah UK